Annual review of Type 2 Diabetes Mellitus. Patient reports feeling generally well. Adherent to Metformin regimen with no reported hypoglycaemic episodes. Diet and exercise maintained, though knee pain has been limiting walking distance recently.
Consultations
48 entries
13
Feb
2026
Diabetes Annual Review
Dr. J Patterson
Annual Review
28
Jan
2026
Knee Pain Review
Dr. R Williams
Follow-Up
15
Jan
2026
BP Check
Nurse S Brown
Routine
02
Dec
2025
Medication Review
Dr. J Patterson
Admin
18
Nov
2025
URTI
Dr. R Williams
Acute
05
Nov
2025
Flu Vaccination
Nurse S Brown
Routine
Diabetes Annual Review
History
Examination
Blood Pressure
138/82 mmHg
Weight
74.2 kg
BMI
27.4
HbA1c
52 mmol/mol
07/02/2026
Foot Exam
Pulses present, sensation intact
Assessment
Type 2 Diabetes Mellitus — reasonable control (HbA1c 52 mmol/mol). Hypertension slightly above target. BMI in overweight range — lifestyle advice given.
Plan
- Continue Metformin 500mg BD
- Repeat BP in 4 weeks — consider Amlodipine uptitration if remains above target
- Dietitian referral discussed — patient to consider
- Annual bloods due August 2026
- Foot check due February 2027
Clinical Codes
[C10E.] Diabetes mellitus Type 2
[XaJQp] Diabetes annual review